Keith Nogueira

This inventor holds 35 USPTO granted patents and 21 published patent applications, plus 5 CIPO patents and 6 EPO patents, primarily in Glucose Monitoring. Top assignee: Medtronic Minimed, Inc.. Active years: 2014-2026.

USPTO Granted Patents = 35 (Patent Applications = 21)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 92(Granted Patents)

Location History:

Northridge, CA (US) (2014 - 2016)
Mission Hills, CA (US) (2018 - 2024)

Company Filing History:

35 out of 1,264

Medtronic Minimed, Inc.

patents

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Glucose Sensors

Sensor Calibration

Outlier Detection

Continuous Monitoring

Personalized Modeling

Adaptive Processing

Signal Calibration

Measurement Simulation

Health Monitoring

Infusion Devices

Error Correction

Mosaic Framework

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12721556 - Methods, systems, and devices for calibration and optimization of glucose sensors and sensor output (2026-09-01),

2. 12626819 - Machine learning models for detecting outliers and erroneous sensor use conditions and correcting, blanking, or terminating glucose sensors (2026-05-12),

3. 12423490 - Model mosaic framework for modeling glucose sensitivity (2025-09-23),

4. 12369825 - Methods, systems, and devices for calibration and optimization of glucose sensors and sensor output (2025-07-29),

5. 12369823 - Optional sensor calibration in continuous glucose monitoring (2025-07-29),

6. 12343144 - Methods, systems, and devices for calibration and optimization of glucose sensors and sensor output (2025-07-01),

7. 12161464 - Micro models and layered prediction models for estimating sensor glucose values and reducing sensor glucose signal blanking (2024-12-10),

8. 12138047 - Micro models and layered prediction models for estimating sensor glucose values and reducing sensor glucose signal blanking (2024-11-12),

9. 12119119 - Methods and systems for real-time sensor measurement simulation (2024-10-15),

10. 12114972 - Methods, systems, and devices for continuous glucose monitoring (2024-10-15),

11. 12082930 - Methods, systems, and devices for calibration and optimization of glucose sensors and sensor output (2024-09-10),

12. 12019039 - Sensor systems, devices, and methods for continuous glucose monitoring (2024-06-25),

13. 11974844 - Sensor systems, devices, and methods for continuous glucose monitoring (2024-05-07),

14. 11963768 - Methods, systems, and devices for calibration and optimization of glucose sensors and sensor output (2024-04-23),

15. 11957464 - Methods, systems, and devices for calibration and optimization of glucose sensors and sensor output (2024-04-16),

Title: Innovations in Continuous Glucose Monitoring: The Contributions of Keith Nogueira

Introduction: Keith Nogueira, based in Mission Hills, CA, is a notable inventor with a remarkable portfolio of 29 patents. His innovative work primarily focuses on improving continuous glucose monitoring (CGM) technology, which plays a critical role in managing diabetes. Nogueira's latest patents reflect his commitment to advancing healthcare technology through sophisticated modeling techniques.

Latest Patents: Among his latest innovations, Nogueira developed methods, systems, and devices that utilize micro models and layered prediction models to enhance the accuracy of sensor glucose value estimations. These advancements aim to reduce sensor glucose signal blanking, thereby providing users with more reliable glucose level readings. The system employs machine learning algorithms to predict sensor glucose values, particularly under challenging outlier conditions. This innovative approach prioritizes models trained for specific outlier scenarios based on real-time sensor data, leading to more consistent and trustworthy glucose monitoring.

Career Highlights: Nogueira's career has been significantly shaped by his role at Medtronic MiniMed, Inc., where he contributes to the development of cutting-edge medical devices. His extensive work in the field has not only resulted in numerous patents but also positioned him as a leader in the industry. His experience and innovations are instrumental in advancing CGM technology, helping countless individuals manage their diabetes more effectively.

Collaborations: Throughout his career, Nogueira has collaborated with talented individuals such as Peter Ajemba and Andrea Varsavsky. These partnerships have fostered a creative environment that promotes the exchange of ideas and spurs further innovation within the field of continuous glucose monitoring.

Conclusion: Keith Nogueira's contributions to the field of continuous glucose monitoring demonstrate his innovative spirit and dedication to improving health outcomes. Through his patents and collaborative efforts, he continues to lead advancements in technology that benefit patients and healthcare providers alike. Nogueira's work exemplifies the profound impact that inventive minds can have on the healthcare landscape, ensuring that innovations lead to practical solutions for everyday challenges.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]